109 related articles for article (PubMed ID: 3372010)
21. The pharmacology study of a new recombinant TNF receptor-hyFc fusion protein.
Lee JH; Cho JH; Yeo J; Lee SH; Yang SH; Sung YC; Kang JH; Park CS
Biologicals; 2013 Mar; 41(2):77-83. PubMed ID: 23190454
[TBL] [Abstract][Full Text] [Related]
22. [Characterization of neutralizing activity of murine monoclonal antibodies for construction of anti-human TNF chimeric antibody].
Zhu CS; Ouyang WM; Liu XS; Cao YX; Zhao N; Jin BQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Nov; 19(6):576-9. PubMed ID: 15182654
[TBL] [Abstract][Full Text] [Related]
23. Dissociation between Limulus neutralisation and in vivo protection in monoclonal antibodies directed against endotoxin core structures.
McConnell JS; Appelmelk BJ; Cohen J
Microb Pathog; 1990 Jul; 9(1):55-9. PubMed ID: 2077344
[TBL] [Abstract][Full Text] [Related]
24. Limited involvement of interleukin-6 in the pathogenesis of lethal septic shock as revealed by the effect of monoclonal antibodies against interleukin-6 or its receptor in various murine models.
Libert C; Vink A; Coulie P; Brouckaert P; Everaerdt B; Van Snick J; Fiers W
Eur J Immunol; 1992 Oct; 22(10):2625-30. PubMed ID: 1327800
[TBL] [Abstract][Full Text] [Related]
25. Analysis of rat natural killer cytotoxic factor (NKCF) produced by rat NK cell lines and the production of a murine monoclonal antibody that neutralizes NKCF.
Ortaldo JR; Winkler-Pickett R; Morgan AC; Woodhouse C; Kantor R; Reynolds CW
J Immunol; 1987 Nov; 139(9):3159-65. PubMed ID: 3668253
[TBL] [Abstract][Full Text] [Related]
26. Lipopolysaccharide-induced cytokine production and mortality in mice treated with Corynebacterium parvum.
Smith SR; Calzetta A; Bankowski J; Kenworthy-Bott L; Terminelli C
J Leukoc Biol; 1993 Jul; 54(1):23-9. PubMed ID: 8336076
[TBL] [Abstract][Full Text] [Related]
27. The mouse/human chimeric monoclonal antibody cA2 neutralizes TNF in vitro and protects transgenic mice from cachexia and TNF lethality in vivo.
Siegel SA; Shealy DJ; Nakada MT; Le J; Woulfe DS; Probert L; Kollias G; Ghrayeb J; Vilcek J; Daddona PE
Cytokine; 1995 Jan; 7(1):15-25. PubMed ID: 7538333
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibodies to human tumor necrosis factors alpha and beta: application for affinity purification, immunoassays, and as structural probes.
Bringman TS; Aggarwal BB
Hybridoma; 1987 Oct; 6(5):489-507. PubMed ID: 2445655
[TBL] [Abstract][Full Text] [Related]
29. Bioassay for interleukin-1, interleukin-6, and tumor necrosis factor-like activities in canine sera.
Yamashita K; Fujinaga T; Hagio M; Miyamoto T; Izumisawa Y; Kotani T
J Vet Med Sci; 1994 Feb; 56(1):103-7. PubMed ID: 8204733
[TBL] [Abstract][Full Text] [Related]
30. Prevention of endotoxin shock by an antibody against leukocyte integrin beta 2 through inhibiting production and action of TNF.
Watanabe S; Mukaida N; Ikeda N; Akiyama M; Harada A; Nakanishi I; Nariuchi H; Watanabe Y; Matsushima K
Int Immunol; 1995 Jul; 7(7):1037-46. PubMed ID: 8527401
[TBL] [Abstract][Full Text] [Related]
31. Synergy between tumor necrosis factor and bacterial products causes hemorrhagic necrosis and lethal shock in normal mice.
Rothstein JL; Schreiber H
Proc Natl Acad Sci U S A; 1988 Jan; 85(2):607-11. PubMed ID: 3422444
[TBL] [Abstract][Full Text] [Related]
32. Differential protective activities of site specific lipoxygenase inhibitors in endotoxic shock and production of tumor necrosis factor.
Schade UF; Engel R; Jakobs D
Int J Immunopharmacol; 1991; 13(5):565-71. PubMed ID: 1783470
[TBL] [Abstract][Full Text] [Related]
33. Natural and recombinant Escherichia coli-derived interferon-gamma differ in their reactivity with monoclonal antibody.
Le J; Rubin BY; Kelker HC; Feit C; Nagler C; Vilcek J
J Immunol; 1984 Mar; 132(3):1300-4. PubMed ID: 6420463
[TBL] [Abstract][Full Text] [Related]
34. Humanization of a mouse monoclonal antibody neutralizing TNF-alpha by guided selection.
Wang Z; Wang Y; Li Z; Li J; Dong Z
J Immunol Methods; 2000 Jul; 241(1-2):171-84. PubMed ID: 10915859
[TBL] [Abstract][Full Text] [Related]
35. Observations on the role of tumor necrosis factor-alpha in a murine model of shock due to Streptococcus pyogenes.
Wayte J; Silva AT; Krausz T; Cohen J
Crit Care Med; 1993 Aug; 21(8):1207-12. PubMed ID: 8339588
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of monoclonal antibody against tumor necrosis factor alpha in an endotoxemic baboon model.
Emerson TE; Lindsey DC; Jesmok GJ; Duerr ML; Fournel MA
Circ Shock; 1992 Oct; 38(2):75-84. PubMed ID: 1423924
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of macrophage-activating cytokines is beneficial in the acute septic response.
Redmond HP; Chavin KD; Bromberg JS; Daly JM
Ann Surg; 1991 Oct; 214(4):502-8; discussion 508-9. PubMed ID: 1659339
[TBL] [Abstract][Full Text] [Related]
38. [Functional properties of cooperative monoclonal antibodies against human tumor necrosis factor].
Vodianyk MO; Chernyshov VP; Humeniuk MIe
Fiziol Zh (1994); 2001; 47(3):73-9. PubMed ID: 11519254
[TBL] [Abstract][Full Text] [Related]
39. A novel xanthine derivative counteracting in vivo tumor necrosis factor alpha toxicity in mice.
Niehörster M; Schönharting M; Wendel A
Circ Shock; 1992 Aug; 37(4):270-3. PubMed ID: 1446384
[TBL] [Abstract][Full Text] [Related]
40. Administration of anti-CD3 monoclonal antibody during experimental Chagas' disease induces CD8+ cell-dependent lethal shock.
Jacobs F; Dubois C; Carlier Y; Goldman M
Clin Exp Immunol; 1996 Feb; 103(2):233-8. PubMed ID: 8565305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
